CD90 highly expressed population harbors a stemness signature and creates an immunosuppressive niche in pancreatic cancer.

Juanjuan Shi,Ping Lu,Wenyan Shen,Ruizhe He,Min-Wei Yang,Yuan Fang,Yong-Wei Sun,Ningning Niu,Jing Xue

DOI: https://doi.org/10.1016/j.canlet.2019.03.051

IF: 9.756

2019-01-01

Cancer Letters

Abstract:Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive disease with no effective treatment. Cancer cells, especially cancer stem cells (CSCs), redirect immune cells to evade immune surveillance and even coopt these immune cells to support their growth and metastasis. However, the identification of CSCs and how CSCs interact with immune cells in PDAC remain uncharacterized. Here, we report that CD90 is expressed on both stromal and tumor cells and that high expression of CD90 is related to a poor prognosis in patients with PDAC. The CD90 highly expressed (CD90hi) population in PDAC cells harbors high stemness features and tumorigenicity. Notably, CD90 acts as an anchor for monocyte/macrophage adhesion, providing a physical interaction between CD90hi cells and monocytes/macrophages. In response, the crosstalk between CD90hi cells and monocytes/macrophages promotes immunosuppressive features of immune cells, which enhance the stemness and epithelial-mesenchymal transition (EMT) of PDAC cells. Moreover, PD-L1 is dominantly expressed in the CD90hi population, providing another strategy for these cells to evade immune surveillance. These findings provide an understanding of the biological significance of CD90 expression in PDAC cells and uncover a novel mechanism for how “stem-like” PDAC cells evade immune surveillance.